Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

edoxaban MeSH Supplementary Concept Data 2025


MeSH Supplementary
edoxaban
Unique ID
C552171
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C552171
Entry Term(s)
DU-176
DU-176b
N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide
N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)ethanediamide p-toluenesulfonate monohydrate
Savaysa
edoxaban tosylate
Pharm Action
Factor Xa Inhibitors
Registry Numbers
NDU3J18APO
0
32W99UE810
Related Numbers
32W99UE810
480449-70-5
Heading Mapped to
*Pyridines
*Thiazoles
Frequency
861
Source
J Clin Pharmacol. 2010 Jul;50(7):743-53
Date of Entry
2010/09/16
Revision Date
2020/02/28
edoxaban Preferred
DU-176b Narrower
DU-176 Narrower
edoxaban tosylate Narrower
N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)ethanediamide p-toluenesulfonate monohydrate Related
Savaysa Related
page delivered in 0.004s